Organisation
Nuclear Medicine
Current researchers
1 - 10 of 35 results
- Simon Arits (Member)
- Jesse Asiedu (Member)
- Kelly Boumon (Member)
- Sophie Bourgeois (Member)
- Amelientje Bracke (Member)
- Vicky Caveliers (Member)
- Veerle De Grove (Member)
- Lynn De Mey (Member)
- Steffi De Trif (Member)
- Jens Debacker (Member)
Projects
1 - 7 of 7
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of a novel chemoenzymatic technology to generate radiofluorinated PET tracersFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- SBO project: Nanobody Life Time imaging to Enhance Surgery (NLITESurgery)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects (OZR EU BONUS)From1 Sep 2020 → 31 Aug 2023Funding: BOF - mobility
- H2020: CSA: EURAMED rocc-n-roll: title EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspectsFrom1 Sep 2020 → 31 Aug 2023Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- Connect 2018: IMMUNE-IMAGE: Specific Imaging of Immune Cell Dynamics Using Novel Tracer StrategiesFrom10 Oct 2018 → 11 Dec 2018Funding: Brussels Capital Region
Publications
21 - 30 of 105
- Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - An interpretable deep learning approach for lesion detection and segmentation on whole-body [18F]FDG PET/CT(2024)Volume: 12926
Authors: Ine Dirks, Marleen Keyaerts, Bart Neyns, Jef Vandemeulebroucke
Number of pages: 10 - F-18-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma(2020)
Authors: Annie Wong, Jason Callahan, Marleen Keyaerts, Bart Neyns, Johanna Mangana, Susanne Aberle, Alan Herschtal, Sonia Fullerton, Donna Milne, Amir Iravani, et al.
- MR of Tendons about the Hip :A Study in Asymptomatic Volunteers(2021)
Authors: Veerle De Grove, Nico Buls, Frederick Vandenbroucke, Maryam Shahabpour, Aldo Scafoglieri, Johan De Mey, Michel De Maeseneer
- Prediction of Response to Neoadjuvant Radiotherapy in Patients with Locally Advanced Rectal Cancer by Means of Sequential 18FDG-PET(2011)
Authors: Hendrik Everaert, A. Hoorens, C Vanhove, Alexandra Sermeus, G Ceulemans, Benedikt Engels, Marieke Vermeersch, Dirk Verellen, D. Urbain, Guy Storme, et al.
Pages: 91-96 - Computer-aided diagnosis and decision support using medical image analysis(2024)
Authors: Ine Dirks, Jef Vandemeulebroucke, Marleen Keyaerts, Bart Neyns
Number of pages: 269 - Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells(2019)
Authors: Inès Dufait, Julian Pardo, David Escors, Y De Vlaeminck, H. Jiang, Marleen Keyaerts, Mark De Ridder, Karine Breckpot
- Evaluation of different types of lithium fluoride thermoluminescent detectors for ring dosimetry in nuclear medicine(2022)
Authors: Olivier Van Hoey, Hasan Moudud, Lara Struelens, Werner Schoonjans, Jeremie Dabin, Dayana Castillo, Sonja Van den Block, Filip Vanhavere
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Y De Vlaeminck, C Goyvaerts, Magali Verdonck, et al.
Pages: 172-182 - Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Authors: Teofila Seremet, Yanina Jansen, Simon Planken, Hassan Njimi, Melanie Delaunoy, Hakim El Housni, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, et al.